Glenmark Generics and Konec Inc. to Stop Marketing Unapproved Nitroglycerin Tablets

• Date: March 16, 2010
• Source: Admin

FDA has ordered Glenmark Generics of Mahwah, N.J., and Konec Inc. of Tucson, Ariz., to stop marketing unapproved nitroglycerin tablets.  FDA has already issued warning letters against these two companies requiring them to remove the unapproved tablets as part of the FDA's Unapproved Drugs Initiative1. Initiative 1 was announced in 2006 in order to address drugs that had not received FDA approval yet being marketed.